Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Minimally Invasive Procedure Breaks the Migraine Cycle

By HospiMedica International staff writers
Posted on 10 Mar 2015
A new study demonstrates that image-guided, intranasal sphenopalatine ganglion (SPG) nerve blocks provided ongoing relief to migraine patients. More...


Researchers at Albany Medical Center (AMC; NY, USA) and SUNY Empire State College (ESC; Saratoga Springs, NY, USA) conducted a retrospective analysis of 112 participants with migraine or cluster headaches, who scored the severity of their symptoms on a visual analog scale (VAS). The researchers then inserted a catheter through the nasal passages and toward the rear of the nasal cavity. A 4% lidocaine solution was then dripped in situ, absorbed through the bone and into the SPG, anesthetizing the nerve bundle in the ganglion and blocking neurotransmission. Depending on the type of headache disorder being treated, the procedure was repeated in the other nostril.

The results showed that before treatment, the patients reported an average VAS score of 8.25, with scores greater than 4 at least 15 days per month. The day after the SPG block, the patient’s scores were cut in half, to an average of 4.1. Thirty days after the procedure, patients reported an average score of 5.25, a 36% decrease from pretreatment. Additionally, 88% of patients indicated that they required less or no migraine medication for ongoing relief. The study was presented at the Society of Interventional Radiology annual scientific meeting, held during March 2015 in Atlanta (GA, USA).

“Administration of lidocaine to the sphenopalatine ganglion acts as a ‘reset button’ for the brain’s migraine circuitry,” said lead author and study presenter interventional radiologist Kenneth Mandato, MD. “When the initial numbing of the lidocaine wears off, the migraine trigger seems to no longer have the maximum effect that it once did. Some patients have reported immediate relief and are making fewer trips to the hospital for emergency headache medicine.”

The SPG is a collection of nerve cells that is closely associated with the trigeminal nerve, the main nerve involved in headache disorders due to its linkage to the brainstem and the meninges. The SPG contains both sensory and autonomic nerves, which supply the lacrimal glands and the membranes lining the nasal cavity and sinuses, which explains why autonomic features, including tearing of the eyes and nasal congestion or discharge, can occur during cluster headache and migraine. The phenomenon is known as trigeminal autonomic reflex.

Related Links:

Albany Medical Center
SUNY Empire State College



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.